Hepion Pharmaceuticals, Inc.
HEPA
$0.06
-$0.03-35.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.16M | 728.50K | 609.70K | 527.90K | 919.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21M | 798.50K | 609.70K | 527.90K | 1.34M |
| Operating Income | -1.21M | -798.50K | -609.70K | -527.90K | -1.34M |
| Income Before Tax | -1.25M | -810.80K | -656.90K | -472.50K | -1.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.25M | -810.80K | -656.90K | -472.50K | -1.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.25M | -810.80K | -656.90K | -472.50K | -1.04M |
| EBIT | -1.21M | -798.50K | -609.70K | -527.90K | -1.34M |
| EBITDA | -- | -- | -602.00K | -520.20K | -1.34M |
| EPS Basic | -0.08 | -0.07 | -0.06 | -0.04 | -0.09 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.08 | -0.07 | -0.06 | -0.04 | -0.09 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 16.19M | 11.62M | 11.68M | 11.62M | 11.33M |
| Average Diluted Shares Outstanding | 16.19M | 11.62M | 11.68M | 11.62M | 11.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |